Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2005 Nov 01; 23(31):7804-10.

View in: PubMed

subject areas

Adult
Aged
Breast Neoplasms
Case-Control Studies
Cohort Studies
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Germ-Line Mutation
Hormone Replacement Therapy
Humans
Incidence
Middle Aged
Ovariectomy
Prospective Studies
Risk Factors
Treatment Outcome

authors with profiles

Olufunmilayo Olopade